GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: JNJ-78278343 | JNJ78278343
Compound class:
Antibody
Comment: Pasritamig (JNJ-78278343) is a bispecific kallikrein related peptidase 2 (KLK2)/CD3e monoclonal antibody. It acts as a T-cell engager targeting KLK2 on tumour cells.
The peptide sequences for the heavy and light chains of pasritamig's KLK2 binding domain are claimed in patent US11965024B2 [1] and are a component of the antibody named KL2B30. The anti-cD3e component is claimed in patent US11827708B2 [2]. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13153 | pasritamig |
Synonyms ![]() |
| JNJ-78278343 | JNJ78278343 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1661 |
| Other databases | |
| Search PubMed clinical trials | pasritamig |
| Search PubMed titles | pasritamig |
| Search PubMed titles/abstracts | pasritamig |